The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 3,701–3,800 of 31,469
Xu, W., Yang, Y., Yuan, G., Zhu, W., Ma, D., & Hu, S. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000129 · Cited by 90
Sathyapalan, T., David, R., Gooderham, N. J., & Atkin, S. L. (2015) · Scientific Reports · doi:10.1038/srep16890 · Cited by 90
Mansur, A. D. P., Roggério, A., Góes, M. F. S., Avakian, S. D., Leal, D. P., Maranhão, R. C., & Strunz, C. M. C. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.058 · Cited by 94
Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats
Xu, W., Liu, J., Ma, D., Yuan, G., Lü, Y., & Yang, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172477 · Cited by 89
Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome
Zhang, Y., Hu, M., Meng, F., Sun, X., Xu, H., Zhang, J., Cui, P., Morina, N., Li, X., Li, W., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.023 · Cited by 90
Jeftic, I. D., Jovicic, N. U., Pantic, J. M., Arsenijević, N., Lukić, M. L., & Pejnovic, N. N. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00178 · Cited by 89
Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men
Wannamethee, S. G., Welsh, P. I., Papacosta, O., LENNON, L. T., Whincup, P. H., & Sattar, N. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2362 · Cited by 92
A Genomewide Search for Type 2 Diabetes–Susceptibility Genes in Indigenous Australians
Busfield, F., Duffy, D. L., Kesting, J. B., Walker, S. M., Lovelock, P. K., Good, D. M., Tate, H., Watego, D., Marczak, M., Hayman, N. E., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338626 · Cited by 88
Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women
Crisafulli, A., Altavilla, D., Marini, H. R., Bitto, A., Cucinotta, D., Frisina, N., Corrado, F., D’Anna, R., Squadrito, G., Adamo, E. B., et al. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200512020-00013 · Cited by 91
Tarkun, İ., Çetinarslan, B., Türemen, E., Şahı̇n, T., Cantürk, Z., & Komşuoğlu, B. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01948 · Cited by 89
Heeba, G. H., & Morsy, M. A. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.10.003 · Cited by 88
Circulating microRNAs as Potential Biomarkers of Endothelial Dysfunction in Obese Children
Khalyfa, A., Gozal, D., Bhattacharjee, R., Khalyfa, A. A., & Gozal, D. (2015) · CHEST Journal · doi:10.1378/chest.15-0799 · Cited by 89
Yanagisawa, N., Shimada, K., Miyazaki, T., Kume, A., Kitamura, Y., Ichikawa, R., Ohmura, H., Kiyanagi, T., Hiki, M., Fukao, K., et al. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.2618 · Cited by 89
Evaluation of Beneficial Metabolic Effects of Berries in High-Fat Fed C57BL/6J Mice
Heyman‐Lindén, L., Axling, U., Blanco, N., Sterner, O., Holm, C., & Berger, K. (2014) · Journal of Nutrition and Metabolism · doi:10.1155/2014/403041 · Cited by 88
Yu, X., Ye, L., Zhang, H., Zhao, J., Wang, G., Guo, C., & Shang, W. (2014) · Journal of Ginseng Research · doi:10.1016/j.jgr.2014.11.004 · Cited by 88
Chiang, J., Lai, N., Chang, J., & Koo, M. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-93 · Cited by 89
Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals
Mercer, E., Rekedal, L., Garg, R., Lü, B., Massarotti, E. M., & Solomon, D. H. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3868 · Cited by 89
Reynolds, J. A., Haque, S., Berry, J., Pemberton, P. W., Teh, L., Ho, P., Gorodkin, R. E., & Bruce, I. N. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/ker352 · Cited by 88
Eliasson, B., Möller-Goede, D. L., Eeg‐Olofsson, K., Wilson, C., Cederholm, J., Fleck, P. R., Diamant, M., Taskinen, M., & Smith, U. (2012) · Diabetologia · doi:10.1007/s00125-011-2447-3 · Cited by 88
Fetuin-A, Type 2 Diabetes, and Risk of Cardiovascular Disease in Older Adults
Jensen, M. K., Bartz, T. M., Mukamal, K. J., Djoussé, L., Kizer, J. R., Tracy, R. P., Zieman, S. J., Rimm, E. B., Siscovick, D. S., Shlipak, M. G., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1591 · Cited by 88
Combined Training Reduces Subclinical Inflammation in Obese Middle-Age Men
Brunelli, D. T., Chacon‐Mikahil, M. P. T., Gáspari, A. F., Lopes, W. A., Bonganha, V., Bonfante, I. L. P., Bellotto, M. L., Libardi, C. A., & Cavaglieri, C. R. (2015) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000658 · Cited by 92
Loss of CTRP1 disrupts glucose and lipid homeostasis
Rodriguez, S., Lei, X., Petersen, P. S., Tan, S. Y., Little, H. C., & Wong, G. W. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00087.2016 · Cited by 85
Candeias, E., Sebastião, I., Cardoso, S., Carvalho, C., Santos, M. S., Oliveira, C. R., Moreira, P. I., & Duarte, A. I. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0622-3 · Cited by 89
Murri, M., Insenser, M. R., Fernández‐Durán, E., San‐Millán, J. L., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.011 · Cited by 88
The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients
ELDerawi, W. A., Naser, I. A., Taleb, M., & Abutair, A. S. (2018) · Nutrients · doi:10.3390/nu11010044 · Cited by 89
Mancusi, C., SIMONE, G. D., Best, L. G., Wang, W., Zhang, Y., Roman, M. J., Lee, E. T., Howard, B. V., & Devereux, R. B. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0862-9 · Cited by 89
Abdulmalek, S. A., & Balbaa, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220779 · Cited by 92
Iino, C., Endo, T., Mikami, K., Hasegawa, T., Kimura, M., Sawada, N., Nakaji, S., & Fukuda, S. (2019) · Hepatology International · doi:10.1007/s12072-019-09987-8 · Cited by 90
Gunning, M. N., Petermann, T. S., Crisosto, N., van Rijn, B. B., de Wilde, M. A., Christ, J. P., Uiterwaal, C. S. P. M., de Jager, W., Eijkemans, M. J. C., Kunselman, A. R., et al. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz036 · Cited by 88
Bao, Y., Xiao, J., Weng, Z., Lü, X., Shen, X., & Wang, F. (2019) · Food Chemistry · doi:10.1016/j.foodchem.2019.125948 · Cited by 95
Arcidiacono, B., CHIEFARI, E. D., Foryst‐Ludwig, A., Currò, G., Navarra, G., Brunetti, F. S., Mirabelli, M., Corigliano, D. M., Kintscher, U., Britti, D., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102912 · Cited by 95
Sotos‐Prieto, M., Ortolá, R., Ruiz‐Canela, M., García‐Esquinas, E., Martínez‐Gómez, D., López‐García, E., Martínez‐González, M. Á., & Rodríguez‐Artalejo, F. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01195-1 · Cited by 91
Dou, Y., Huang, R., Li, Q., Liu, Y., Li, Y., Chen, H., Ai, G., Xie, J., Zeng, H., Chen, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111312 · Cited by 88
Trouwborst, I., Gijbels, A., Jardon, K. M. C., Siebelink, E., Hul, G. B. J., Wanders, L., Erdõs, B., Péter, S., Singh‐Povel, C. M., den Bosch, J. D. V., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.12.002 · Cited by 90
Kim, J. Y., Han, S., & Yang, B. (2013) · Obesity · doi:10.1002/oby.20020 · Cited by 88
The Association of Fetuin-A With Cardiovascular Disease Mortality in Older Community-Dwelling Adults
Laughlin, G. A., Cummins, K. M., Wassel, C. L., Daniels, L. B., & Ix, J. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.038 · Cited by 88
Liu, X., Miller, Y. D., Burton, N. W., & Brown, W. J. (2008) · British Journal of Sports Medicine · doi:10.1136/bjsm.2008.051144 · Cited by 87
RetractedEffoe, V. S., Correa, A., Chen, H., LACY, M. E., & Bertoni, A. G. (2015) · Diabetes Care · doi:10.2337/dc15-0221 · Cited by 89
Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
Franks, S., Webber, L. J., Goh, M. J., Valentine, A., White, D. M., Conway, G. S., Wiltshire, S., & McCarthy, M. I. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0369 · Cited by 88
Consequences of obstructive sleep apnea on metabolic profile: A Population‐Based Survey
Togeiro, S. M., Carneiro, G., Filho, F. F. R., Zanella, M. T., Santos‐Silva, R., Taddei, J. A., Bittencourt, L., & Tufik, S. (2013) · Obesity · doi:10.1002/oby.20288 · Cited by 90
Endothelial dysfunction, ADMA and insulin resistance in essential hypertension
Perticone, F., Sciacqua, A., Maio, R., Perticone, M., Leone, G. G., Bruni, R., Cello, S. D., Pascale, A., Talarico, G., Greco, L., et al. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.12.131 · Cited by 88
The endocrine profile of subcutaneous and visceral adipose tissue of obese patients
Dolinkova, M., Dostálová, I., Lacinová, Z., Michalský, D., Haluzíková, D., Mráz, M., Kasalicky, M., & Haluzı́k, M. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.05.001 · Cited by 89
Uygun, A., Kadayıfçı, A., Demirci, H., Sağlam, M., Sakın, Y. S., Öztürk, K., Polat, Z., Karslıoğlu, Y., & Bolu, E. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.11.007 · Cited by 88
Ara, I., Larsen, S., Stallknecht, B. M., Guerra, B., Morales‐Álamo, D., Andersen, J. L., Ponce‐González, J. G., Guadalupe‐Grau, A., Galbo, H., Calbet, J. A. L., et al. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.123 · Cited by 88
Clark, C. R., Ommerborn, M. J., Hickson, D. A., Grooms, K. N., Sims, M., Taylor, H. A., & Albert, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063254 · Cited by 90
Reinehr, T., Stoffel‐Wagner, B., & Roth, C. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2745 · Cited by 88
Watanabe, K., Petro, B. J., Shlimon, A. E., & Unterman, T. G. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.070605 · Cited by 88
Genetic Polymorphisms in Peroxisome Proliferator-Activated Receptor δ Associated With Obesity
Shin, H. D., Park, B. L., Kim, L. H., Jung, H. S., Cho, Y. M., Moon, M. K., Park, Y. J., Lee, H. K., & Park, K. S. (2004) · Diabetes · doi:10.2337/diabetes.53.3.847 · Cited by 88
Anorexia in chronic obstructive pulmonary disease — Association to cachexia and hormonal derangement
Koehler, F., Doehner, W., Hoernig, S., Witt, C. C., Anker, S. D., & John, M. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.07.088 · Cited by 88
Yoo, H. J., Hwang, S. Y., Hong, H. C., Choi, H. Y., Yang, S. J., Choi, D. S., Baik, S. H., Blüher, M., Youn, B., & Choi, K. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055744 · Cited by 85
Miyazaki, Y., & DeFronzo, R. A. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00880.x · Cited by 89
Johannsen, N. M., Swift, D. L., Johnson, W. D., Dixit, V. D., Earnest, C. P., Blair, S. N., & Church, T. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031319 · Cited by 96
Ruotolo, G., Båvenholm, P., Brismar, K., Efendić, S., Ericsson, C.-G., Fairé, U. D., Nilsson, J., & Hamsten, A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00591-4 · Cited by 87
Nguyen, Q. M., Srinivasan, S. R., Xu, J.-H., Chen, W., Hassig, S. E., Rice, J. C., & Berenson, G. S. (2011) · Diabetes Care · doi:10.2337/dc11-0919 · Cited by 90
Krishnaveni, G. V., Hill, J. C., Veena, S. R., Geetha, S., Jayakumar, M. N., Karat, C., & Fall, C. H. D. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.06.002 · Cited by 91
Mogul, H. R., Lee, P., Whitman, B. Y., Zipf, W. B., Frey, M., Myers, S. E., Cahan, M., Pinyerd, B., & Southren, A. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2212 · Cited by 90
Prior, S. J., Blumenthal, J. B., Katzel, L. I., Goldberg, A. P., & Ryan, A. S. (2014) · Diabetes Care · doi:10.2337/dc13-2358 · Cited by 92
Sullivan, T., Miao, Z., Dairaghi, D. J., Krasinski, A., Wang, Y., Zhao, B. N., Baumgart, T., Ertl, L. S., Pennell, A. M. K., Seitz, L., et al. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00316.2013 · Cited by 90
Pontiroli, A. E., Pizzocri, P., Koprivec, D., Vedani, P., Marchi, M. D., Arcelloni, C., Paroni, R. C., Esposito, K., & Giugliano, D. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500195 · Cited by 88
Oosterwerff, M. M., Eekhoff, E. M. W., van Schoor, N. M., Boeke, A. J. P., Nanayakkara, P. W. B., Meijnen, R., Knol, D. L., Kramer, M. H. H., & Lips, P. T. A. M. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.069260 · Cited by 88
Cranford, T. L., Enos, R. T., Velázquez, K. T., McClellan, J. L., Davis, J. M., Singh, U. P., Nagarkatti, M., Nagarkatti, P. S., Robinson, C. M., & Murphy, E. A. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.244 · Cited by 96
Junker, A. E., Gluud, L. L., Holst, J. J., Knop, F. K., & Vilsbøll, T. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12462 · Cited by 89
Parham, M., Heidari, S., Khoramirad, A., Hozoori, M., Hosseinzadeh, F., Bakhtyari, L., & Vafaeimanesh, J. (2014) · The Review of Diabetic Studies · doi:10.1900/rds.2014.11.190 · Cited by 88
Brugnara, L., Murillo, S., Novials, A., Rojo‐Martínez, G., Soriguer, F., Goday, A., Calle‐Pascual, A. L., Castaño, L. A., Gaztambide, S., Valdés, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160959 · Cited by 91
Ability of Alternative Indices of Insulin Sensitivity to Predict Cardiovascular Risk
Howard, G., Bergman, R. N., Wagenknecht, L. E., Haffner, S. M., Savage, P. J., Saad, M. F., Laws, A., & D’Agostino, R. B. (1998) · Annals of Epidemiology · doi:10.1016/s1047-2797(98)00002-7 · Cited by 88
Plasma Leptin and Blood Pressure in Men: Graded Association Independent of Body Mass and Fat Pattern
Barba, G., Russo, O., Siani, A., Iacone, R., Farinaro, E., Gerardi, M. C., Russo, P., Valle, E. D., & Strazzullo, P. (2003) · Obesity Research · doi:10.1038/oby.2003.25 · Cited by 88
The Satiating Effect of Dietary Protein Is Unrelated to Postprandial Ghrelin Secretion
Moran, L., Luscombe‐Marsh, N. D., Noakes, M., Wittert, G., Keogh, J. B., & Clifton, P. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0701 · Cited by 89
Beta cell function declines with age in glucose tolerant Caucasians
Chiu, K. C., Lee, N. P., Cohan, P., & Chuang, L. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01132.x · Cited by 88
Insulin Resistance is Associated with Depression Risk in Polycystic Ovary Syndrome
Greenwood, E. A., Pasch, L. A., Cedars, M. I., Legro, R. S., Eisenberg, E., & Huddleston, H. G. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.03.009 · Cited by 88
Horáková, D., Štěpánek, L., Janout, V., Janoutová, J., Pastucha, D., Kollárová, H., Petráková, A., Štěpánek, L., Husár, R., & Martiník, K. (2019) · Medicina · doi:10.3390/medicina55050158 · Cited by 87
“The HOMA-IR was calculated with the following formula (glucose levels in mmol/L, insulin levels in mIU/L) [7]:”
MethodMohan, V., Amutha, A., Ranjani, H., Unnikrishnan, R., Datta, M., Anjana, R. M., Staimez, L., Ali, M. K., & Narayan, K. M. V. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0259 · Cited by 82
Mitchell, C., McGregor, R., D’Souza, R., Thorstensen, E., Markworth, J., Fanning, A., Poppitt, S., & Cameron-Smith, D. (2015) · Nutrients · doi:10.3390/nu7105420 · Cited by 87
Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero
Rø, T. B., Ludvigsen, H. V., Carlsen, S. M., & Vanky, E. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2012.712319 · Cited by 85
Wood, R. J., Fernandez, M. L., Sharman, M. J., Silvestre, R., Greene, C. M., Zern, T. L., Shrestha, S., Judelson, D. A., Gomez, A. L., Kraemer, W. J., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2006.08.021 · Cited by 87
Kerksick, C., Thomas, A., Campbell, B., Taylor, L., Wilborn, C., Marcello, B., Roberts, M., Pfau, E., Grimstvedt, M., Opusunju, J., et al. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-23 · Cited by 126
Amstrup, A. K., Sikjær, T., Pedersen, S. B., Heickendorff, L., Mosekilde, L., & Rejnmark, L. (2015) · Clinical Endocrinology · doi:10.1111/cen.12942 · Cited by 87
Effect of genetic and environmental influences on cardiometabolic risk factors: a twin study
Jermendy, G., Horváth, T., Littvay, L., Steinbach, R., Jermendy, Á. L., Tárnoki, Á. D., Tárnoki, D. L., Métneki, J., & Osztovits, J. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-96 · Cited by 87
Bone Turnover Is Suppressed in Insulin Resistance, Independent of Adiposity
Tonks, K., White, C. P., J. Center, Samocha-Bonet, D., & Greenfield, J. (2017) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2016-3282 · Cited by 80
Hannon, T. S., Kahn, S. E., Utzschneider, K. M., Buchanan, T. A., Nadeau, K. J., Zeitler, P. S., Ehrmann, D. A., Arslanian, S. A., Caprio, S., Edelstein, S. L., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13005 · Cited by 92
Behrouz, V., Jazayeri, S., Aryaeian, N., Zahedi, M. J., & Hosseini, F. Z. (2017) · Middle East Journal of Digestive Diseases · doi:10.15171/mejdd.2017.66 · Cited by 87
Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study
Brahimaj, A., Rivadeneira, F., Muka, T., Sijbrands, E., Franco, O., Dehghan, A., & Kavousi, M. (2019) · Diabetologia · doi:10.1007/s00125-019-4921-2 · Cited by 81
Sun, H., Liu, X., Long, S. R., Wang, T., Ge, H., Wang, Y., Yu, S., Xue, Y., Zhang, Y., Li, X., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172526 · Cited by 87
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
Kim, Y., Han, E., Lee, J. S., Lee, H. W., Kim, B. K., Kim, M. K., Kim, H. S., Park, J. Y., Kim, D. Y., Ahn, S. H., et al. (2021) · Gut and Liver · doi:10.5009/gnl210084 · Cited by 87
Tagliamonte, S., Laiola, M., Ferracane, R., Vitale, M., Gallo, M. A., Meslier, V., Pons, N., Ercolini, D., & Vitaglione, P. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02538-8 · Cited by 95
He, H., Xie, Y., Chen, Q., Li, Y., Li, X.-X., Mu, Y.-K., Duo, X., Gao, Y., & Zheng, J. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02396-8 · Cited by 93
Gutiérrez-Grobe, Y., Chávez-Tapia, N. C., Sánchez-Valle, V., Gavilanes-Espinar, J. G., Ponciano‐Rodríguez, G., Uribe, M., & Méndez‐Sánchez, N. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30931-7 · Cited by 86
Moran, L., Noakes, M., Clifton, P. M., Wittert, G., le Roux, C. W., Ghatei, M. A., Bloom, S. R., & Norman, R. J. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1603 · Cited by 88
Marfella, R., D’Amico, M., Filippo, C. D., Baldi, A., Siniscalchi, M., Sasso, F. C., Portoghese, M., Carbonara, O., Crescenzi, B., Sangiuolo, P., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.073 · Cited by 86
Joglekar, C. V., Fall, C. H. D., Deshpande, V. U., Joshi, N. P., Bhalerao, A., Solat, V. A., Deokar, T. M., Chougule, S., Leary, S. D., Osmond, C., et al. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803679 · Cited by 87
Predicting the development of the metabolically healthy obese phenotype
Achilike, I., Hazuda, H. P., Fowler, S. P., Aung, K., & Lorenzo, C. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.113 · Cited by 87
Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia
Tonorezos, E. S., Vega, G. L., Sklar, C. A., Chou, J. F., Moskowitz, C. S., Mo, Q., Church, T. S., Ross, R., Janiszewski, P. M., & Oeffinger, K. C. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.22964 · Cited by 88
Hirai, M., Suzuki, S., Hinokio, Y., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1951 · Cited by 87
Seo, Y. Y., Cho, Y. K., Bae, J.-C., Seo, M. H., Park, S. E., Rhee, E., Park, C., Oh, K.-W., Park, S., & Lee, W. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.1.41 · Cited by 87
Adalı, E., Yıldızhan, R., Kurdoğlu, M., Kolusarı, A., Edirne, T., Şahin, H. G., Yıldızhan, B., & Kamacı, M. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600604 · Cited by 87
Insulin resistance and acne: a new risk factor for men?
Prete, M. D., Mauriello, M. C., Faggiano, A., Somma, C. D., Monfrecola, G., Fabbrocini, G., & Colao, A. (2012) · Endocrine · doi:10.1007/s12020-012-9647-6 · Cited by 87
Six-Year Change in Youth Physical Activity and Effect on Fasting Insulin and HOMA-IR
Jago, R., Wedderkopp, N., Kristensen, P. L., Møller, N. C., Andersen, L. B., Cooper, A. R., & Froberg, K. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.07.007 · Cited by 87
Malathion exposure and insulin resistance among a group of farmers in Al-Sharkia governorate
Raafat, N., Abass, M. A., & Salem, H. M. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.07.108 · Cited by 88
C-peptide Predicts the Remission of Type 2 Diabetes After Bariatric Surgery
Lee, W., Chong, K., Ser, K., Chen, J., Lee, Y.-C., Chen, S., Su, Y., & Tsai, M.-H. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0565-0 · Cited by 88
Ivey, K. L., Hodgson, J. M., Kerr, D. A., Lewis, J. R., Thompson, P. L., & Prince, R. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.294 · Cited by 92
Obese Adolescents with Type 2 Diabetes Mellitus Have Hippocampal and Frontal Lobe Volume Reductions
Bruehl, H., Sweat, V., Tirsi, A., Shah, B. C., & Convit, A. J. (2011) · Neuroscience & Medicine · doi:10.4236/nm.2011.21005 · Cited by 88
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
